OmniCyte

OmniCyte is an immunology company leveraging our proprietary targeted platform technology to develop therapeutics for oncology, infectious & autoimmune diseases

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Branford, CT, USA
  • Currency USD
  • Founded January 2017
  • Employees 4
  • Incorporation Type LLC
  • Website omnicyte.com

Company Summary

We are a pre-clinical stage biotech company and have developed a novel Immune targeting platform technology that selectively activates the immune system to target specific cells or pathogens. Our technology can be engineered to safely target the immune system to attack numerous different tumor types, pathogens or autoimmune responses, without activating off-target immune responses.

Team

Advisors

  • Hans Christinger, MBA
    Unconfirmed
    Boris Shor, Ph.D.
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free